サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：電子処方箋ソリューション市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
市場調査レポート
商品コード
1310406

電子処方箋ソリューション市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

E-Prescribing Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Usage Method ; By Substances ; By Specialties ; By End User ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
電子処方箋ソリューション市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年
出版日: 2023年07月12日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の電子処方箋ソリューション市場規模は5倍以上に拡大、2029年までに138億米ドルに達する

世界の電子処方箋ソリューション市場は、規制薬物の不正や乱用の削減、疾患の有病率の上昇、医療ミスの削減への注目の高まりにより、活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consultingは、最近の調査で、2022年の世界の電子処方箋ソリューション市場規模を27億4,000万米ドルと推定しました。2023年から2029年までの予測期間中、世界の電子処方箋ソリューション市場規模はCAGR 26.04%の大幅な成長を遂げ、2029年には137億9,000万米ドルに達するとBlueWeaveは予測しています。世界の電子処方箋ソリューション市場の主な成長促進要因としては、ヘルスケアITソリューションの導入拡大、投薬ミスを最小限に抑え患者の安全性を向上させる必要性、電子処方箋システムの導入を促進する政府の取り組み、デジタル化とヘルスケア自動化の重視の高まりなどが挙げられます。電子処方箋ソリューションは、推奨用量、アレルギー、薬物相互作用の可能性など、医薬品に関する正確で最新の情報を医療従事者に提供することで、投薬ミスを減らし、患者の安全性を高める上で極めて重要な役割を担っています。ヘルスケアにおいて患者の安全が優先される中、電子処方箋ソリューションの需要は増加の一途をたどっています。また、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の世界の有病率の上昇は、電子処方箋ソリューションの使用をさらに必要にしています。これらのソリューションは、慢性疾患を抱える患者の薬物療法を効果的に管理し、ミスを減らしながらタイムリーな処方を保証します。その結果、慢性疾患の負担が増加していることが、世界の電子処方箋ソリューション市場拡大の原動力となっています。しかし、導入コストが高く、セキュリティやワークフローに関する懸念が、予測期間中の市場全体の成長を抑制すると予想されています。

本レポートの詳細な分析により、世界の電子処方箋ソリューション市場の成長可能性、今後の動向、統計に関する情報を提供します。また、総市場規模の予測を促進する要因にも注目しています。当レポートは、世界の電子処方箋ソリューション市場における最近の技術動向や、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することをお約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の電子処方箋ソリューション市場に関する洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 障害の有病率の上昇
      • 医療過誤の削減への関心の高まり
      • 詐欺や規制薬物の乱用の削減に注目が集まる
    • 抑制要因
      • 導入コストが高い
      • セキュリティとワークフローに関する懸念
    • 機会
      • COVID-19の影響で統合テレパスソリューションの採用が増加
      • ヘルスケアインフラに対する政府投資の増加
    • 課題
      • 消費者のテクノロジーに対する意識の欠如
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界の電子処方箋ソリューション市場概要

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
      • ソリューション
      • 統合ソリューション
      • スタンドアロンソリューション
      • サービス
      • サポート
      • 実装
      • トレーニング
      • 通信網
    • 配信モード別
      • ウェブ/クラウドベース
      • オンプレミス
    • 利用方法別
      • ハンドヘルド
      • コンピュータベースのデバイス
    • 物質別
      • 規制物質
      • 非管理物質
    • 専門分野別
      • 腫瘍学
      • スポーツ医学
      • 神経内科
      • 心臓病学
      • その他
    • エンドユーザー別
      • 病院
      • 勤務医
      • 薬局
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東およびアフリカ（MEA）

第5章 北米の電子処方箋ソリューション市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 配信モード別
    • 利用方法別
    • 物質別
    • 専門分野別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第6章 欧州の電子処方箋ソリューション市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 配信モード別
    • 利用方法別
    • 物質別
    • 専門分野別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他欧州

第7章 アジア太平洋の電子処方箋ソリューション市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 配信モード別
    • 利用方法別
    • 物質別
    • 専門分野別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • APACのその他の地域

第8章 ラテンアメリカの電子処方箋ソリューション市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 配信モード別
    • 利用方法別
    • 物質別
    • 専門分野別
    • エンドユーザー別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • 中南米のその他の地域

第9章 中東およびアフリカの電子処方箋ソリューション市場

  • 市場規模と予測、2019～2029年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 配信モード別
    • 利用方法別
    • 物質別
    • 専門分野別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • MEAのその他の地域

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界の電子処方箋ソリューション企業の市場シェア分析、2022年
  • 動作パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の電子処方箋ソリューション市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

  • Medical information technology, Inc.
  • Eclinicalworks
  • Athenahealth
  • Epic Systems Corporation
  • Change healthcare
  • Surescripts
  • Practice Fusion
  • Drfirst
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • NextGen Healthcare, Inc.
  • eMDs, Inc.
  • Greenway Health, LLC
  • Stratice Healthcare
  • Computer Programs and Systems Inc.
  • Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

  • 定性的調査
    • 一次および2次調査
  • 定量的調査
  • 市場内訳とデータの三角測量
    • 2次調査
    • 1次調査
  • 1次調査回答者の地域別内訳
  • 前提と制限
目次
Product Code: BWC23562

Global E-Prescribing Solutions Market Size Zooming More Than 5X to Touch USD 13.8 Billion by 2029.

Global e-prescribing solutions market is flourishing because of an increasing focus on the reduction of fraud and abuse of controlled substances and rising prevalence of disorders, increasing focus on reducing medical errors.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global e-prescribing solutions market size at USD 2.74 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global e-prescribing solutions market size to grow at a significant CAGR of 26.04% reaching a value of USD 13.79 billion by 2029. Major growth drivers for the global e-prescribing solutions market include an increasing adoption of healthcare IT solutions, the need to minimize medication errors and improve patient safety, government initiatives promoting the adoption of e-prescribing systems, and the growing emphasis on digitization and healthcare automation. E-prescribing solutions have a pivotal role in reducing medication errors and enhancing patient safety by equipping healthcare professionals with accurate and up-to-date information on medications, including dosage recommendations, allergies, and potential drug interactions. As healthcare prioritizes patient safety, the demand for e-prescribing solutions continues to grow. Also, the rising prevalence of chronic diseases like diabetes, cardiovascular diseases, and respiratory conditions on a global scale further necessitates the use of e-prescribing solutions. These solutions effectively manage medication for patients with chronic conditions, ensuring timely prescriptions while reducing errors. Consequently, the increasing burden of chronic diseases acts as a driving force behind the expanding global e-prescribing solutions market. However, high cost of deployment and concern regarding security and workflow are anticipated to restrain the overall market growth during the forecast period.

Global E-Prescribing Solutions Market - Overview:

The global e-prescribing solutions market refers to the market encompassing electronic prescription systems used in the healthcare industry. E-prescribing, or electronic prescribing, involves the computer-based generation, transmission, and management of medical prescriptions, replacing traditional paper-based methods. The e-prescribing solutions market includes software platforms and solutions that enable healthcare professionals to electronically create, transmit, and process prescriptions, as well as access patient medication history, drug interaction alerts, and formulary information. The global e-prescribing solutions market is driven by the need to enhance patient safety, minimize medication errors, improve healthcare efficiency, and comply with government regulations promoting digital healthcare initiatives.

Impact of COVID-19 on Global E-Prescribing Solutions Market:

COVID-19 pandemic had a positive impact on the global e-prescribing solutions market. With the focus on reducing physical contact and ensuring patient safety, there has been a heightened demand for contactless healthcare solutions. E-prescribing systems have played a crucial role in enabling remote prescribing, minimizing the need for in-person visits to healthcare facilities. The pandemic has accelerated the adoption of e-prescribing solutions as healthcare providers strive to streamline workflows, reduce transmission risks, and ensure continuity of care. Moreover, the transition towards telemedicine and virtual consultations has underscored the significance of e-prescribing, consequently fueling market expansion both during and after the COVID-19 pandemic.

Global E-Prescribing Solutions Market - By End User:

On basis of the End User, the global e-prescribing solutions market is segmented into Hospital, Office-based Physicians, and Pharmacy segments. The office-based physicians segment holds the highest share in the global e-prescribing solutions market by end user. These include the widespread adoption of e-prescribing systems in outpatient settings, the convenience and efficiency it offers to office-based physicians in managing prescriptions, and the ability to seamlessly integrate e-prescribing with electronic health records for streamlined patient care. Meanwhile, the hospital segment dominates the market in second place. Hospitals are large healthcare facilities that handle a significant volume of patient visits and medication prescriptions. Implementing e-prescribing systems in hospitals helps improve efficiency, reduce medication errors, and enhance patient safety. Additionally, hospitals often have more complex medication management needs, including controlled substances and specialized treatments, which can be effectively managed through e-prescribing solutions. The integration of e-prescribing systems with other hospital systems, such as electronic health records and pharmacy systems, further enhances workflow and coordination, contributing to the segment's significant market share.

Competitive Landscape:

Major players operating in the Global E-Prescribing Solutions Market include: Medical information technology, Inc., Eclinicalworks, Athenahealth, Epic Systems Corporation, Change healthcare, Surescripts, Practice Fusion, Drfirst, Allscripts Healthcare Solutions, Inc., Cerner Corporation, NextGen Healthcare, Inc., eMDs, Inc., Greenway Health, LLC, Stratice Healthcare, and Computer Programs and Systems Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global E-Prescribing Solutions Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global E-Prescribing Solutions Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global E-Prescribing Solutions Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising prevalence of disorders
      • 3.2.1.2. Increasing focus on reducing medical errors
      • 3.2.1.3. Rise in focus on the reduction of fraud and abuse of controlled substances
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of deployment
      • 3.2.2.2. Concern regarding security and workflow
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing adoption of integrated telepath solution due to COVID-19
      • 3.2.3.2. Increase in government investments on healthcare infrastructure
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of technological awareness among consumers
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global E-Prescribing Solutions Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Solutions
      • 4.2.1.1.1. Integrated Solutions
      • 4.2.1.1.2. Standalone Solutions
      • 4.2.1.2. Services
      • 4.2.1.2.1. Support
      • 4.2.1.2.2. Implementation
      • 4.2.1.2.3. Training
      • 4.2.1.2.4. Network
    • 4.2.2. By Delivery Mode
      • 4.2.2.1. Web/Cloud-Based
      • 4.2.2.2. On-premises
    • 4.2.3. By Usage Method
      • 4.2.3.1. Handheld
      • 4.2.3.2. Computer-based Devices
    • 4.2.4. By Substances
      • 4.2.4.1. Controlled Substances
      • 4.2.4.2. Non-controlled Substances
    • 4.2.5. By Specialties
      • 4.2.5.1. Oncology
      • 4.2.5.2. Sports Medicine
      • 4.2.5.3. Neurology
      • 4.2.5.4. Cardiology
      • 4.2.5.5. Others
    • 4.2.6. By End User
      • 4.2.6.1. Hospital
      • 4.2.6.2. Office-based Physicians
      • 4.2.6.3. Pharmacy
    • 4.2.7. By Region
      • 4.2.7.1. North America
      • 4.2.7.2. Europe
      • 4.2.7.3. Asia Pacific (APAC)
      • 4.2.7.4. Latin America (LATAM)
      • 4.2.7.5. Middle East and Africa (MEA)

5. North America E-Prescribing Solutions Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Delivery Mode
    • 5.2.3. By Usage Method
    • 5.2.4. By Substances
    • 5.2.5. By Specialties
    • 5.2.6. By End User
    • 5.2.7. By Country
      • 5.2.7.1. United States
      • 5.2.7.1.1. By Product
      • 5.2.7.1.2. By Delivery Mode
      • 5.2.7.1.3. By Usage Method
      • 5.2.7.1.4. By Substances
      • 5.2.7.1.5. By Specialties
      • 5.2.7.1.6. By End User
      • 5.2.7.2. Canada
      • 5.2.7.2.1. By Product
      • 5.2.7.2.2. By Delivery Mode
      • 5.2.7.2.3. By Usage Method
      • 5.2.7.2.4. By Substances
      • 5.2.7.2.5. By Specialties
      • 5.2.7.2.6. By End User

6. Europe E-Prescribing Solutions Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Delivery Mode
    • 6.2.3. By Usage Method
    • 6.2.4. By Substances
    • 6.2.5. By Specialties
    • 6.2.6. By End User
    • 6.2.7. By Country
      • 6.2.7.1. Germany
      • 6.2.7.1.1. By Product
      • 6.2.7.1.2. By Delivery Mode
      • 6.2.7.1.3. By Usage Method
      • 6.2.7.1.4. By Substances
      • 6.2.7.1.5. By Specialties
      • 6.2.7.1.6. By End User
      • 6.2.7.2. United Kingdom
      • 6.2.7.2.1. By Product
      • 6.2.7.2.2. By Delivery Mode
      • 6.2.7.2.3. By Usage Method
      • 6.2.7.2.4. By Substances
      • 6.2.7.2.5. By Specialties
      • 6.2.7.2.6. By End User
      • 6.2.7.3. Italy
      • 6.2.7.3.1. By Product
      • 6.2.7.3.2. By Delivery Mode
      • 6.2.7.3.3. By Usage Method
      • 6.2.7.3.4. By Substances
      • 6.2.7.3.5. By Specialties
      • 6.2.7.3.6. By End User
      • 6.2.7.4. France
      • 6.2.7.4.1. By Product
      • 6.2.7.4.2. By Delivery Mode
      • 6.2.7.4.3. By Usage Method
      • 6.2.7.4.4. By Substances
      • 6.2.7.4.5. By Specialties
      • 6.2.7.4.6. By End User
      • 6.2.7.5. Spain
      • 6.2.7.5.1. By Product
      • 6.2.7.5.2. By Delivery Mode
      • 6.2.7.5.3. By Usage Method
      • 6.2.7.5.4. By Substances
      • 6.2.7.5.5. By Specialties
      • 6.2.7.5.6. By End User
      • 6.2.7.6. Belgium
      • 6.2.7.6.1. By Product
      • 6.2.7.6.2. By Delivery Mode
      • 6.2.7.6.3. By Usage Method
      • 6.2.7.6.4. By Substances
      • 6.2.7.6.5. By Specialties
      • 6.2.7.6.6. By End User
      • 6.2.7.7. Russia
      • 6.2.7.7.1. By Product
      • 6.2.7.7.2. By Delivery Mode
      • 6.2.7.7.3. By Usage Method
      • 6.2.7.7.4. By Substances
      • 6.2.7.7.5. By Specialties
      • 6.2.7.7.6. By End User
      • 6.2.7.8. The Netherlands
      • 6.2.7.8.1. By Product
      • 6.2.7.8.2. By Delivery Mode
      • 6.2.7.8.3. By Usage Method
      • 6.2.7.8.4. By Substances
      • 6.2.7.8.5. By Specialties
      • 6.2.7.8.6. By End User
      • 6.2.7.9. Rest of Europe
      • 6.2.7.9.1. By Product
      • 6.2.7.9.2. By Delivery Mode
      • 6.2.7.9.3. By Usage Method
      • 6.2.7.9.4. By Substances
      • 6.2.7.9.5. By Specialties
      • 6.2.7.9.6. By End User

7. Asia-Pacific E-Prescribing Solutions Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Delivery Mode
    • 7.2.3. By Usage Method
    • 7.2.4. By Substances
    • 7.2.5. By Specialties
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Product
      • 7.2.6.1.2. By Delivery Mode
      • 7.2.6.1.3. By Usage Method
      • 7.2.6.1.4. By Substances
      • 7.2.6.1.5. By Specialties
      • 7.2.6.1.6. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Product
      • 7.2.6.2.2. By Delivery Mode
      • 7.2.6.2.3. By Usage Method
      • 7.2.6.2.4. By Substances
      • 7.2.6.2.5. By Specialties
      • 7.2.6.2.6. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Product
      • 7.2.6.3.2. By Delivery Mode
      • 7.2.6.3.3. By Usage Method
      • 7.2.6.3.4. By Substances
      • 7.2.6.3.5. By Specialties
      • 7.2.6.3.6. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Product
      • 7.2.6.4.2. By Delivery Mode
      • 7.2.6.4.3. By Usage Method
      • 7.2.6.4.4. By Substances
      • 7.2.6.4.5. By Specialties
      • 7.2.6.4.6. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Product
      • 7.2.6.5.2. By Delivery Mode
      • 7.2.6.5.3. By Usage Method
      • 7.2.6.5.4. By Substances
      • 7.2.6.5.5. By Specialties
      • 7.2.6.5.6. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Product
      • 7.2.6.6.2. By Delivery Mode
      • 7.2.6.6.3. By Usage Method
      • 7.2.6.6.4. By Substances
      • 7.2.6.6.5. By Specialties
      • 7.2.6.6.6. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Product
      • 7.2.6.7.2. By Delivery Mode
      • 7.2.6.7.3. By Usage Method
      • 7.2.6.7.4. By Substances
      • 7.2.6.7.5. By Specialties
      • 7.2.6.7.6. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Product
      • 7.2.6.8.2. By Delivery Mode
      • 7.2.6.8.3. By Usage Method
      • 7.2.6.8.4. By Substances
      • 7.2.6.8.5. By Specialties
      • 7.2.6.8.6. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Product
      • 7.2.6.9.2. By Delivery Mode
      • 7.2.6.9.3. By Usage Method
      • 7.2.6.9.4. By Substances
      • 7.2.6.9.5. By Specialties
      • 7.2.6.9.6. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Product
      • 7.2.6.10.2. By Delivery Mode
      • 7.2.6.10.3. By Usage Method
      • 7.2.6.10.4. By Substances
      • 7.2.6.10.5. By Specialties
      • 7.2.6.10.6. By End User

8. Latin America E-Prescribing Solutions Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Delivery Mode
    • 8.2.3. By Usage Method
    • 8.2.4. By Substances
    • 8.2.5. By Specialties
    • 8.2.6. By End User
    • 8.2.7. By Country
      • 8.2.7.1. Brazil
      • 8.2.7.1.1. By Product
      • 8.2.7.1.2. By Delivery Mode
      • 8.2.7.1.3. By Usage Method
      • 8.2.7.1.4. By Substances
      • 8.2.7.1.5. By Specialties
      • 8.2.7.1.6. By End User
      • 8.2.7.2. Mexico
      • 8.2.7.2.1. By Product
      • 8.2.7.2.2. By Delivery Mode
      • 8.2.7.2.3. By Usage Method
      • 8.2.7.2.4. By Substances
      • 8.2.7.2.5. By Specialties
      • 8.2.7.2.6. By End User
      • 8.2.7.3. Argentina
      • 8.2.7.3.1. By Product
      • 8.2.7.3.2. By Delivery Mode
      • 8.2.7.3.3. By Usage Method
      • 8.2.7.3.4. By Substances
      • 8.2.7.3.5. By Specialties
      • 8.2.7.3.6. By End User
      • 8.2.7.4. Peru
      • 8.2.7.4.1. By Product
      • 8.2.7.4.2. By Delivery Mode
      • 8.2.7.4.3. By Usage Method
      • 8.2.7.4.4. By Substances
      • 8.2.7.4.5. By Specialties
      • 8.2.7.4.6. By End User
      • 8.2.7.5. Rest of LATAM
      • 8.2.7.5.1. By Product
      • 8.2.7.5.2. By Delivery Mode
      • 8.2.7.5.3. By Usage Method
      • 8.2.7.5.4. By Substances
      • 8.2.7.5.5. By Specialties
      • 8.2.7.5.6. By End User

9. Middle East & Africa E-Prescribing Solutions Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Delivery Mode
    • 9.2.3. By Usage Method
    • 9.2.4. By Substances
    • 9.2.5. By Specialties
    • 9.2.6. By End User
    • 9.2.7. By Country
      • 9.2.7.1. Saudi Arabia
      • 9.2.7.1.1. By Product
      • 9.2.7.1.2. By Delivery Mode
      • 9.2.7.1.3. By Usage Method
      • 9.2.7.1.4. By Substances
      • 9.2.7.1.5. By Specialties
      • 9.2.7.1.6. By End User
      • 9.2.7.2. UAE
      • 9.2.7.2.1. By Product
      • 9.2.7.2.2. By Delivery Mode
      • 9.2.7.2.3. By Usage Method
      • 9.2.7.2.4. By Substances
      • 9.2.7.2.5. By Specialties
      • 9.2.7.2.6. By End User
      • 9.2.7.3. Qatar
      • 9.2.7.3.1. By Product
      • 9.2.7.3.2. By Delivery Mode
      • 9.2.7.3.3. By Usage Method
      • 9.2.7.3.4. By Substances
      • 9.2.7.3.5. By Specialties
      • 9.2.7.3.6. By End User
      • 9.2.7.4. Kuwait
      • 9.2.7.4.1. By Product
      • 9.2.7.4.2. By Delivery Mode
      • 9.2.7.4.3. By Usage Method
      • 9.2.7.4.4. By Substances
      • 9.2.7.4.5. By Specialties
      • 9.2.7.4.6. By End User
      • 9.2.7.5. South Africa
      • 9.2.7.5.1. By Product
      • 9.2.7.5.2. By Delivery Mode
      • 9.2.7.5.3. By Usage Method
      • 9.2.7.5.4. By Substances
      • 9.2.7.5.5. By Specialties
      • 9.2.7.5.6. By End User
      • 9.2.7.6. Nigeria
      • 9.2.7.6.1. By Product
      • 9.2.7.6.2. By Delivery Mode
      • 9.2.7.6.3. By Usage Method
      • 9.2.7.6.4. By Substances
      • 9.2.7.6.5. By Specialties
      • 9.2.7.6.6. By End User
      • 9.2.7.7. Algeria
      • 9.2.7.7.1. By Product
      • 9.2.7.7.2. By Delivery Mode
      • 9.2.7.7.3. By Usage Method
      • 9.2.7.7.4. By Substances
      • 9.2.7.7.5. By Specialties
      • 9.2.7.7.6. By End User
      • 9.2.7.8. Rest of MEA
      • 9.2.7.8.1. By Product
      • 9.2.7.8.2. By Delivery Mode
      • 9.2.7.8.3. By Usage Method
      • 9.2.7.8.4. By Substances
      • 9.2.7.8.5. By Specialties
      • 9.2.7.8.6. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global E-Prescribing Solutions Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global E-Prescribing Solutions Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Medical information technology, Inc.
  • 12.2. Eclinicalworks
  • 12.3. Athenahealth
  • 12.4. Epic Systems Corporation
  • 12.5. Change healthcare
  • 12.6. Surescripts
  • 12.7. Practice Fusion
  • 12.8. Drfirst
  • 12.9. Allscripts Healthcare Solutions, Inc.
  • 12.10. Cerner Corporation
  • 12.11. NextGen Healthcare, Inc.
  • 12.12. eMDs, Inc.
  • 12.13. Greenway Health, LLC
  • 12.14. Stratice Healthcare
  • 12.15. Computer Programs and Systems Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations